調查批次:CHT2015-01 | 檢體寄出日期:2015-02-02 | 報告回收截止日期:2015-02-09 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
1.42 |
-0.27 |
-16.0 |
-1.9 |
-1.1 |
-64 |
2.55 |
-0.60 |
-19.0 |
-2.4 |
-0.6 |
-80 |
RH07b | RH07 | 4 |
2 |
3 |
1.82 |
0.13 |
7.7 |
0.9 |
0.9 |
31 |
3.65 |
0.50 |
15.9 |
2.0 |
0.8 |
67 |
RH14 | RH14 | 7 |
2 |
3 |
1.86 |
0.17 |
10.1 |
1.2 |
1.1 |
40 |
3.93 |
0.78 |
24.8 |
3.1 |
1.2 |
104 |
RH15 | RH15 | 7 |
2 |
5 |
1.55 |
-0.14 |
-8.3 |
-1.0 |
-0.4 |
-33 |
2.26 |
-0.89 |
-28.3 |
-3.6 |
-0.9 |
-119 |
CL009 | CL009 | 3 |
2 |
5 |
1.37 |
-0.32 |
-18.9 |
-2.3 |
-1.4 |
-76 |
2.25 |
-0.90 |
-28.6 |
-3.6 |
-1.0 |
-120 |
CL010 | CL010 | 3 |
2 |
5 |
1.76 |
0.07 |
4.1 |
0.5 |
0.6 |
17 |
2.61 |
-0.54 |
-17.1 |
-2.2 |
-0.5 |
-72 |
CL012 | CL012 | 7 |
2 |
3 |
1.69 |
0.00 |
0.0 |
0.0 |
0.3 |
0 |
3.67 |
0.52 |
16.5 |
2.1 |
0.8 |
69 |
CL013 | CL013 | 3 |
2 |
5 |
1.54 |
-0.15 |
-8.9 |
-1.1 |
-0.5 |
-36 |
2.48 |
-0.67 |
-21.3 |
-2.7 |
-0.7 |
-89 |
CL015 | CL015 | 7 |
2 |
3 |
1.78 |
0.09 |
5.3 |
0.6 |
0.7 |
21 |
3.70 |
0.55 |
17.5 |
2.2 |
0.9 |
73 |
Median of RIA Group |
1.69 |
2.61 |
||||||||||||||
Range of RIA Group |
1.37 - 1.86 |
2.25 - 3.93 |
||||||||||||||
Robust mean of RIA Group |
1.64 ( n = 9 ) |
3.01 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.20 |
0.80 |
||||||||||||||
CV of RIA Group |
12.2% |
26.6% |
||||||||||||||
Median of European RIA Labs |
1.61 ( n = 99 ) |
2.80 ( n = 101 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.41 - 1.82 |
2.56 - 3.01 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
4 |
9 |
1.80 |
0.11 |
6.5 |
0.8 |
1.2 |
26 |
3.19 |
0.04 |
1.3 |
0.2 |
0.6 |
5 |
RH02c | RH02 | 7 |
4 |
1 |
1.35 |
-0.34 |
-20.1 |
-2.4 |
-0.6 |
-81 |
1.88 |
-1.27 |
-40.3 |
-5.1 |
-8.1 |
-169 |
RH06 | RH06 | 3 |
4 |
9 |
1.83 |
0.14 |
8.3 |
1.0 |
1.3 |
33 |
3.15 |
0.00 |
0.0 |
0.0 |
0.3 |
0 |
RH07a | RH07 | 2 |
4 |
2 |
1.40 |
-0.29 |
-17.2 |
-2.1 |
-0.4 |
-69 |
3.19 |
0.04 |
1.3 |
0.2 |
0.6 |
5 |
RH12 | RH12 | 4 |
4 |
2 |
1.42 |
-0.27 |
-16.0 |
-1.9 |
-0.4 |
-64 |
3.25 |
0.10 |
3.2 |
0.4 |
1.0 |
13 |
RH19 | RH19 | 2 |
4 |
2 |
1.32 |
-0.37 |
-21.9 |
-2.6 |
-0.8 |
-88 |
2.99 |
-0.16 |
-5.1 |
-0.6 |
-0.7 |
-21 |
RH20 | RH20 | 2 |
4 |
7 |
1.52 |
-0.17 |
-10.1 |
-1.2 |
0.0 |
-40 |
3.07 |
-0.08 |
-2.5 |
-0.3 |
-0.2 |
-11 |
CL005 | CL005 | 7 |
4 |
9 |
1.81 |
0.12 |
7.1 |
0.9 |
1.2 |
29 |
3.12 |
-0.03 |
-1.0 |
-0.1 |
0.1 |
-4 |
CL006a | CL006 | 4 |
4 |
7 |
1.43 |
-0.26 |
-15.4 |
-1.9 |
-0.3 |
-62 |
3.02 |
-0.13 |
-4.1 |
-0.5 |
-0.5 |
-17 |
CL008 | CL008 | 4 |
4 |
2 |
1.26 |
-0.43 |
-25.4 |
-3.1 |
-1.0 |
-102 |
3.23 |
0.08 |
2.5 |
0.3 |
0.9 |
11 |
CL011 | CL011 | 3 |
4 |
13 |
1.74 |
0.05 |
3.0 |
0.4 |
0.9 |
12 |
3.19 |
0.04 |
1.3 |
0.2 |
0.6 |
5 |
CL014b | CL014 | 2 |
4 |
1 |
1.25 |
-0.44 |
-26.0 |
-3.1 |
-1.0 |
-105 |
1.74 |
-1.41 |
-44.8 |
-5.6 |
-9.1 |
-188 |
Median of CLIA Group |
1.43 |
3.14 |
||||||||||||||
Range of CLIA Group |
1.25 - 1.83 |
1.74 - 3.25 |
||||||||||||||
Robust mean of CLIA Group |
1.51 ( n = 12 ) |
3.10 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.25 |
0.15 |
||||||||||||||
CV of CLIA Group |
16.6% |
4.8% |
||||||||||||||
Median of European CLIA Labs |
1.70 ( n = 1020 ) |
3.19 ( n = 1007 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.39 - 1.83 |
2.59 - 3.37 |
||||||||||||||
Median of All Labs |
1.54 |
3.12 |
||||||||||||||
Range of All Labs |
1.25 - 1.86 |
1.74 - 3.93 |
||||||||||||||
Robust mean of All Labs |
1.57 ( n = 21 ) |
2.98 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.24 |
0.62 |
||||||||||||||
CV of All Labs |
15.3% |
20.8%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.69 |
3.15 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.39 - 1.84 |
2.49 - 3.38 |
||||||||||||||
Mean of All European Labs |
1.63 ( n = 1180 ) |
2.99 ( n = 1171 ) |
||||||||||||||
SD of All European Labs |
0.21 |
0.54 |
||||||||||||||
CV of All European Labs |
13.0% |
18.0% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.14 |
0.25 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-07-01